EZH2 and hepatocellular carcinoma: In addition, EZH2 contributes to the progression of hepatocellular carcinoma by increasing the expression of additional immune checkpoints such as Gal-9 and TIM-3 ligand through H3K27 trimethylation at the miR-22 promoter, with a positive role in the progression of hepatocellular carcinoma139.